Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience

Objective: To examine disease control and survival after stereotactic body radiotherapy (SBRT) for medically inoperable, early-stage non–small cell lung cancer (NSCLC) and determine associations of pretreatment 18F-fluorodeoxyglucose–positron emission tomography (FDG-PET) maximum standardized uptake...

Full description

Bibliographic Details
Main Authors: Corey J. Hobbs, MD, Stephen J. Ko, MD, Nitesh N. Paryani, MD, Joseph M. Accurso, MD, Kenneth R. Olivier, MD, Yolanda I. Garces, MD, Sean S. Park, MD, MS, PhD, Christopher L. Hallemeier, MD, Steven E. Schild, MD, Sujay A. Vora, MD, Jonathan B. Ashman, MD, PhD, William G. Rule, MD, Johnny R. Bowers, BS, Michael G. Heckman, MS, Nancy N. Diehl, MBA, Robert C. Miller, MD
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454817300711

Similar Items

Similar Items